Chemed Corporation

CHE Healthcare Medical Care Facilities

Chemed Corporation’s revenue for fiscal 2025 (year ended December 2025) was $2.5 billion, up 4.06% from fiscal 2024.

Revenue
+10.6%
EPS
+23.1%
Free cash flow
−45.3%

Quarter to September 2026, against a year earlier

533.55 15.09 −2.75%
Market cap
$7.0B
P/E
25.5×
Fwd P/E
24.0×
Dividend yield
0.47%
F-score
6/9
Altman Z
11.69
Beneish M
−2.76
Dividend safety
100/100

Chemed Corporation (CHE) P/B ratio

Alert me on P/B ratio

As of 5 November 2026, Chemed Corporation (CHE) trades at a P/B ratio of 8.1×. Over the past ten years it has ranged from 3.8× (January 2015) to 13.3× (December 2021); the current reading is higher than 51% of that period. That is above the Medical Care Facilities industry median of 3.1× and above the Healthcare sector median of 2.3×.

P/B ratio, daily

Embed this chart

Annual newest first

Period P/B ratio Change
FY2025 6.3× (11.58%)
FY2024 7.1× (10.42%)
FY2023 7.9× (16.19%)
FY2022 9.5× (28.77%)
FY2021 13.3× 41.07%
FY2020 9.4× (2.32%)
FY2019 9.7× 25.49%
FY2018 7.7× 4.82%
FY2017 7.3× 44.83%
FY2016 5.1× 2.92%

Quarterly newest first

Period P/B ratio Change
Sep 2026 7.7× 3.63%
Jun 2026 7.4× 21.28%
Mar 2026 6.1× (3.15%)
Dec 2025 6.3× 5.08%
43 more quarters

Against its own ten years

Low 3.8× High 13.3×
Ten-year median 8.0×
Current reading's percentile 47

P/B ratio against peers

What P/B ratio is

Price to Book Value tells an investor how much the market pays for a company’s shares relative to the accounting net worth that belongs to common shareholders.

Stock Price ÷ (Common Equity (Total) (latest quarter) ÷ Shares (Basic, Weighted) (latest quarter))

The full definition of P/B ratio →

More on CHE